Cerence stock holds at USD 3.00 as revenue recovery remains key

Published on 09/23/2026 at 16:02 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Cerence stock traded at USD 3.00 on September 23, 2026, while its latest reported revenue was USD 236.4 million. Cash flow and cost savings remain central.

CRNC, US1567271093, Illustration mit AI erstellt.

Cerence Inc. stock (ISIN US1567271093) traded at USD 3.00 on September 23, 2026, according to the available market quote, while the latest dated company figures cited in the search results show revenue of USD 236.4 million for fiscal year 2025. The combination leaves revenue recovery and cash generation as the central operating measures.

Revenue remains the key measure

Cerence reported USD 236.4 million in fiscal year 2025 revenue, compared with its initial guidance range of USD 236 million to USD 247 million. The lower end of that range was therefore only USD 0.4 million above the reported full-year figure, a concrete comparison that places the result near the bottom of the earlier outlook.

The same company update cited positive cash flow from operations of USD 6.1 million and a transformation plan targeting USD 35 million to USD 40 million in annualized cost savings. These figures matter because the stock story depends not only on platform launches but also on whether lower costs translate into repeatable cash generation.

Cost savings meet execution risk

Cerence also reported 22 platform launches in fiscal year 2024, including six generative artificial intelligence solutions and four launches in the fourth quarter. That launch count provides an operating reference point, but it belongs to fiscal year 2024 and is historical context rather than a current-period earnings measure.

For investors, the comparison between USD 236.4 million of fiscal year 2025 revenue and USD 6.1 million of operating cash flow is more informative than the launch count alone. Revenue reached the guidance floor while operating cash flow turned positive, leaving execution on cost savings and new platform adoption as the measurable next steps.

Stock trades at USD 3.00

Cerence stock traded at USD 3.00 on Nasdaq on September 23, 2026. The price is the article's single reference quote; the dated market figure places the stock in the context of the company's fiscal year 2025 revenue and its USD 35 million to USD 40 million cost-saving target.